POT1 and central nervous system cancer: The ∼10-fold difference in RHPS4 sensitivity between PFSK-1/DAOY embryonal cells and C6/GB-1 glioma cells is plausibly due to competitive binding of RHPS4 and POT1 to the 3′ overhang.